Monitoring the Effects of Anti-angiogenesis on the Radiation Sensitivity of Pancreatic Cancer Xenografts Using Dynamic Contrast-Enhanced CT

dc.contributor.authorCao, Ning
dc.contributor.authorCao, Minsong
dc.contributor.authorChin-Sinex, Helen
dc.contributor.authorMendonca, Marc
dc.contributor.authorKo, Song-Chu
dc.contributor.authorStantz, Keith M
dc.contributor.departmentDepartment of Radiation Oncology, IU School of Medicineen_US
dc.date.accessioned2016-01-29T15:13:26Z
dc.date.available2016-01-29T15:13:26Z
dc.date.issued2014-02-01
dc.description.abstractPurpose To image the intra-tumor vascular physiological status of pancreatic tumors xenografts and their response to anti-angiogenic therapy using Dynamic Contrast-Enhanced CT (DCE-CT), and to identify parameters of vascular physiology associated with tumor X-ray sensitivity following anti-angiogenic therapy. Methods and Materials Nude mice bearing human BxPC-3 pancreatic tumor xenografts were treated with 5Gy of radiation therapy (RT), either a low-dose (40mg/kg) or a high-dose (150mg/kg) of DC101, the anti-VEGF receptor-2 anti-angiogenesis antibody, or with combination of low or high dose DC101 and 5Gy RT (DC101-plus-RT). DCE-CT scans were longitudinally acquired over three week period post-DC101 treatment. Parametric maps of tumor perfusion and fractional plasma volume (Fp) were calculated and their averaged values and histogram distributions evaluated and compared to controls, from which a more homogeneous physiological window was observed 1-week post-DC101. Mice receiving a combination of DC101-plus-RT(5Gy) were imaged baseline prior to receiving DC101 and 1-week after DC101 (prior to RT). Changes in perfusion and Fp were compared with alternation in tumor growth delay for RT and DC101-plus-RT(5Gy) treated tumors. Results Pretreatment with low or high doses of DC101 prior to RT significantly delayed tumor growth by an average 7.9 days compared to RT alone (p≤0.01). The increase in tumor growth delay for the DC101-plus-RT treated tumors was strongly associated with changes in tumor perfusion (ΔP>−15%) compared to RT treated tumors alone (p=0.01). In addition, further analysis revealed a trend linking the tumor’s increased growth delay to its tumor volume-to-DC101 dose ratio. Conclusions DCE-CT is capable of monitoring changes in intra-tumor physiological parameter of tumor perfusion in response to anti-angiogenic therapy of a pancreatic human tumor xenograft that was associated with enhanced radiation response.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationCao, N., Cao, M., Chin-Sinex, H., Mendonca, M., Ko, S.-C., & Stantz, K. M. (2014). Monitoring the Effects of Anti-angiogenesis on the Radiation Sensitivity of Pancreatic Cancer Xenografts Using Dynamic Contrast-Enhanced CT. International Journal of Radiation Oncology, Biology, Physics, 88(2), 412–418. http://doi.org/10.1016/j.ijrobp.2013.11.002en_US
dc.identifier.issn0360-3016en_US
dc.identifier.urihttps://hdl.handle.net/1805/8202
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.ijrobp.2013.11.002en_US
dc.relation.journalInternational journal of radiation oncology, biology, physicsen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAngiogenesis Inhibitorsen_US
dc.subjecttherapeutic useen_US
dc.subjectAntibodies, Monoclonalen_US
dc.subjectPancreatic Neoplasmsen_US
dc.subjectTherapyen_US
dc.subjectRadiation Toleranceen_US
dc.subjectdrug effectsen_US
dc.subjectTomography, X-Ray Computeden_US
dc.subjectmethodsen_US
dc.titleMonitoring the Effects of Anti-angiogenesis on the Radiation Sensitivity of Pancreatic Cancer Xenografts Using Dynamic Contrast-Enhanced CTen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms548348.pdf
Size:
1.69 MB
Format:
Adobe Portable Document Format
Description:
Author's manuscript
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: